Digital Therapeutics Global Logo

Digitally Revolutionizing the Future of Global Healthcare

EVENT HAS NOW PASSED

Global healthcare is amidst a digital revolution!

 

Development of digital health software, tools and devices create not only value, but also enhance patient outcomes, building new sustainable business models for those embracing change. However, the paradigm shift from traditional pharma to companion and standalone digital therapeutics is complex, with many barriers to adoption.

 

Attend this conference to explore the challenges and opportunities related to the adoption, implementation and transition required to incorporate digital therapeutics into the commercial pharma portfolio.

Learn From Our Digital Health Experts

Jessica Shull, Director of Digital Therapeutics, Vicore Pharma

Mikaela K Odlander, Director and Head of Digital Therapeutics EMEAA, Orexo Pharmaceuticals

Dr Sachin S Shah, Global Medical Partner, Digital Health & Devices, GSK

Dr Deepti Sodhi Jaggi, Chief Strategy Officer (CSO), Better Therapeutics

Bert Hartog, Research and Development Operations, Senior Director Clinical Innovation, The Janssen Pharmaceutical Companies of Johnson & Johnson

Zina Manji, M.S., PharmD, RAC, Senior Director, Regulatory Affairs Lead – Innovation, US, GSK

Eleftheria Pissadaki, PhD, Manager, Systems Neuroscientist, Biogen Digital Health (BDH), Biogen 

Emily Luvison, Principal Lead Cybersecurity Compliance for Digital Health Technologies, Genentech

Gergely Vertes, Medical Device Innovation Lead, UCB

Smit Patel, Director of Digital Medicine, DIME, Digital Medicine Society

Dario Motti, PhD, Global Principal Scientist, Digital Health Technologies, Roche

Loreen Brown, Global Head of Patient Support Services, Medocity

Walter Greenleaf PhD, Neuroscientist, Virtual Reality, and Digital Health Expert, Virtual Human Interaction Lab, Stanford University

Dominick Kennerson, Digital & Commercial Innovation, Global Head G4A Digital Health Partnerships, Bayer

Basker Gummadi, Senior Director Digital Therapeutics, Bristol Myers Squibb

Megan Coder, VP of Global Policy, Digital Therapeutics Alliance

Rick Bartels, Managing Partner, DTxCC | Digital Therapeutics Commercialization Consultants

This event will provide you with the necessary tools to:

  • Create and refine the roadmap for successful development, integration and implementation of digital therapeutics within the current pharma portfolio
  • Prepare for the digital age, convey the message, gain buy-in and develop the mindset required to embrace digital medicine at scale
  • Navigate the regulatory, reimbursement and commercialization landscape of DTx, to define suitable routes to market and effective business models
  • Leverage real world evidence to create value with digital health tools, unlocking sustainable opportunities for pharma, patients and stakeholders
  • Develop digital therapeutics that facilitate adherence, improve efficacy, enhance outcomes and reduce costs in administering healthcare as standalone or companion solutions
  • Create strategic partnerships by identifying and selecting suitable partners and solutions providers who can add value and accelerate the advancement of DTx

Digital Therapeutics Global Agenda

Tuesday 18 January 2022

 

07:25 – 07:30 Opening Remarks from AMG World

 

07:30 – 08:30 Clinical Development & Validation of Digital Therapeutics

Panelists:

Dario Motti, Global Principal Scientist, Digital Health Technologies, Roche
Bert Hartog, Research and Development Operations, Senior Director Clinical Innovation, The Janssen Pharmaceutical Companies of Johnson & Johnson
Dr Sachin S Shah, Global Medical Partner, Digital Health & Devices, GSK
Gergely Vertes, Medical Device Innovation Lead, UCB

 

 

 

08:35 – 09:35 Accelerating the Journey Towards Compliance, Reimbursement & Commercialization of
Digital Therapeutics

Moderator:

Rick Bartels, Managing Partner, DTxCC (Digital Therapeutics Commercialization Consultants)

Panelists:

Zina Manji, M.S., PharmD, RAC, Senior Director, Regulatory Affairs Lead – Innovation, US, GSK
Dr Deepti Sodhi Jaggi,Chief Strategy Officer (CSO), Better Therapeutics
Jessica Shull, Director of Digital Therapeutics, Vicore Pharma
Mikaela K Odlander, Director and Head of Digital Therapeutics EMEAA, Orexo Pharmaceuticals

 

 

09:40 – 10:10 Finding the Analogue in the Digital World: A Retrospective View on the Role of Digital
Therapeutics for Neuro-Degenerative Disease

Presenter:

Eleftheria Pissadaki, PhD, Manager, Systems Neuroscientist, Biogen Digital Health (BDH), Biogen

 

 

10:15 – 10:45 US Healthcare System and the Digital Therapeutics/Digital Health Reimbursement Landscape

Rick Bartels, Managing Partner, DTxCC (Digital Therapeutics Commercialization Consultants)

 

10:50 – 11:20 Networking Break and Virtual Exhibition

 

 

11:20 – 11:50 Digital Therapeutics and Digital Health from a Cybersecurity Perspective

Presenter:

Emily Luvison, Principal Lead Cybersecurity Compliance for Digital Health Technologies,
Genentech

11:55 – 12:55 Networking Lunch and Virtual Exhibition

 

 

13:00 – 14:00 Education, Partnerships, Technology and Opportunity: The Building Blocks for Advancing
Digital Therapeutics

Moderator:

Loreen M Brown, LMSW, Global Head, Digital Patient Support Solution, Medocity

Panellists:
Basker Gummadi, Senior Director Digital Therapeutics, Bristol Myers Squibb
Smit Patel, Director of Digital Medicine, DIME, Digital Medicine Society
Dominick Kennerson, Digital & Commercial Innovation, Global Head G4A Digital Health
Partnerships, Bayer
Megan Coder, VP of Global Policy, Digital Therapeutics Alliance
Walter Greenleaf PhD, Neuroscientist, Virtual Reality and Digital Health Expert, Virtual Human Interaction Lab, Stanford University

 

 

14:05 – 14:35 Embracing Digital Therapeutics and the Progressive Future of Digital Health

Presenter:
Smit Patel, Director of Digital Medicine, DIME, Digital Medicine Society

14:40 Close of the conference

Who Should Attend:

Digital Therapeutics Global is designed for VP’s, Directors, Heads, Managers and Scientists from:

 

  • Digital Therapeutics / DTx
  • Digital Health / Digital Medicine / Personalized Medicine / Precision Medicine
  • Digital Healthcare / Connected Health
  • Clinical Innovation / Clinical Development / Clinical R&D
  • Digital Patient Health / Patient- Centricity / Patient Outcomes / Patient Insights / Real World Evidence (RWE)
  • Regulatory Affairs / Medical Affairs
  • Emerging Technology / Innovation
  • Commercial Innovation
  • Data Science & Analytics
  • Artificial Intelligence (AI) / Machine Learning (ML)

Our sponsors include technology, service & solution providers specializing in:

 

  • Digital Therapeutics / DTx
  • App, Platform and Software Development
  • Virtual Reality (VR) & Augmented Reality (AR)
  • Data Science & Analytics
  • Artificial Intelligence (AI) / Machine Learning (ML)
  • Cloud Services & Connectivity
  • Cybersecurity
  • Commercialization & Strategy Consulting

2022 Sponsors:

DTxCC

Sponsorship Opportunities:

Recent disruption has continued to re-shape the conventional approach to networking, creating an opportunity to continue business within a virtual setting.

 

Our attendees are actively working through their operational and transformational challenges, but they also require support from dedicated solution providers who can offer guidance, expertise and technology to help solve unique business problems.

 

It is critical that the vendor community continues to support their customers through open discussions and information exchange; as well as nurture existing relationships and building a pipeline of new and valuable leads.

 

For more information on how we are uniquely placed to help you shape and deliver your message to your target audience, contact us now!

 

Simon Wright
Commercial Director
Simon.wright@amg-world.co.uk